1. Home
  2. VKTX vs MDU Comparison

VKTX vs MDU Comparison

Compare VKTX & MDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • MDU
  • Stock Information
  • Founded
  • VKTX 2012
  • MDU 1924
  • Country
  • VKTX United States
  • MDU United States
  • Employees
  • VKTX N/A
  • MDU N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • MDU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • VKTX Health Care
  • MDU Industrials
  • Exchange
  • VKTX Nasdaq
  • MDU Nasdaq
  • Market Cap
  • VKTX 3.5B
  • MDU 3.5B
  • IPO Year
  • VKTX 2015
  • MDU N/A
  • Fundamental
  • Price
  • VKTX $40.03
  • MDU $16.46
  • Analyst Decision
  • VKTX Strong Buy
  • MDU Buy
  • Analyst Count
  • VKTX 13
  • MDU 2
  • Target Price
  • VKTX $86.92
  • MDU $17.50
  • AVG Volume (30 Days)
  • VKTX 4.6M
  • MDU 1.5M
  • Earning Date
  • VKTX 07-23-2025
  • MDU 08-07-2025
  • Dividend Yield
  • VKTX N/A
  • MDU 3.13%
  • EPS Growth
  • VKTX N/A
  • MDU N/A
  • EPS
  • VKTX N/A
  • MDU 1.04
  • Revenue
  • VKTX N/A
  • MDU $1,851,251,000.00
  • Revenue This Year
  • VKTX N/A
  • MDU $9.67
  • Revenue Next Year
  • VKTX $338.60
  • MDU $2.49
  • P/E Ratio
  • VKTX N/A
  • MDU $18.90
  • Revenue Growth
  • VKTX N/A
  • MDU 761.55
  • 52 Week Low
  • VKTX $18.92
  • MDU $13.44
  • 52 Week High
  • VKTX $81.73
  • MDU $20.39
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 69.97
  • MDU 43.46
  • Support Level
  • VKTX $39.35
  • MDU $16.29
  • Resistance Level
  • VKTX $41.68
  • MDU $17.06
  • Average True Range (ATR)
  • VKTX 2.06
  • MDU 0.43
  • MACD
  • VKTX 0.56
  • MDU -0.08
  • Stochastic Oscillator
  • VKTX 84.10
  • MDU 22.29

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About MDU MDU Resources Group Inc. (Holding Company)

MDU Resources Group Inc operates in three business segments, which include the electric segment, which generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming; The natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington; The pipeline segment provides natural gas transportation and underground storage services through a regulated pipeline system in the Rocky Mountain and northern Great Plains regions of the United States.

Share on Social Networks: